Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). (Q48733770)

15 February 2018

title

Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). (English)

1 reference

15 February 2018

1 reference

1

1 reference

15 February 2018

Jürgen Debus

5

object named as

Juergen Debus

1 reference

15 February 2018

Verena Widmer

2

1 reference

15 February 2018

Christoph Thilmann

3

1 reference

15 February 2018

Holger Hof

4

1 reference

15 February 2018

Daniela Schulz-Ertner

6

1 reference

15 February 2018

language of work or name

English

0 references

publication date

1 November 2005

1 reference

15 February 2018

published in

Cancer

1 reference

15 February 2018

volume

104

1 reference

15 February 2018

issue

10

1 reference

15 February 2018

page(s)

2168-2173

1 reference

15 February 2018

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

Stereotactic single high dose radiation therapy of benign intracranial meningiomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

Reoperation for recurrent glioblastoma and anaplastic astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

The role of chemotherapy in recurrent malignant gliomas: an overview

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Radiosurgery of acoustic neurinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

The radiosurgery of glioblastoma multiforme in cases of recurrence. The Heidelberg experiences compared to the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Value of radiosurgery in first-line therapy of glioblastoma multiforme. The Heidelberg experience and review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

The Physics of Radiosurgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Comparison of radiosurgery treatment modalities based on physical dose distributions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Stereotactic radiosurgery for recurrent malignant gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Recurrent glioblastoma multiforme: potential benefits using fractionated stereotactic radiotherapy and concurrent taxol.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Stereotactic imaging for radiotherapy: accuracy of CT, MRI, PET and SPECT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Photogrammetric accuracy measurements of head holder systems used for fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Correction of spatial distortion in MR imaging: a prerequisite for accurate stereotaxy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

[Stereotactic one-time irradiation (radiosurgery). The methods, indications and results]

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Survival analysis part I: basic concepts and first analyses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Survival analysis part IV: further concepts and methods in survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Reirradiation of primary CNS tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Operation and permanent low activity 125I brachytheraphy for recurrent high-grade astrocytomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Stereotactic radiosurgery for recurrent gliomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21429

7 January 2021

Identifiers

DOI

10.1002/CNCR.21429

1 reference

15 February 2018

PubMed ID

16220556

1 reference

15 February 2018